Skip to content

Angiogenesis in Early Breast Cancer for Prognosis Prediction

Angiogenesis in Early Breast Cancer for Prognosis Prediction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00599105
Enrollment
700
Registered
2008-01-23
Start date
2000-11-30
Completion date
2010-07-31
Last updated
2010-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Lesions

Brief summary

This study will investigate the association of angiogenesis in breast cancer measured by magnetic resonance imaging and biomarkers with long-term prognosis of patients.

Interventions

PROCEDUREmagnetic resonance imaging

MRI contrast agent, 0.1 mmol/kg

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient with a breast mass highly suspicious for malignancy from clinical, mammographic or sonographic examination. * The study has been explained to the patient when she is scheduled for surgery. * Healthy normal volunteers for imaging protocol optimization.

Exclusion criteria

* Pregnancy * Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material, * Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities, * Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion, * Patients with implanted prosthetic heart valves, * Patients with pacemakers, neuro-stimulation devices, * A breast mass with features of benign tumor * The patients unwilling to participate in the study or fail to sign the consent form

Design outcomes

Primary

MeasureTime frame
To investigate whether breast cancer with a higher angiogenesis activity is associated with a unfavorable outcome.5 years from completion of enrollment

Secondary

MeasureTime frame
To investigate whether angiogenesis of breast cancer is associated wit lymph node statusat completion of enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026